Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Special Report ALHC Stock Surges 400%—Here's Why the Bulls Aren't DoneBy Chris Markoch. Published: 1/26/2026. 
At a Glance - Alignment Healthcare stock is up more than 400% since April 2024, as improving Medicare Advantage cost trends and disciplined growth have driven a fundamental re-rating.
- ALHC’s value-based care model positions the company to benefit from a Medicare rebound as hospital economics stabilize and utilization normalizes into 2026.
- While ALHC stock remains technically overextended, the bullish trend is intact, with pullbacks toward key support levels offering favorable risk-reward entries.
Alignment Healthcare Inc. (NASDAQ: ALHC) is an example of why even buy-and-hold investors should leave room to be nimble. ALHC stock is up more than 58% in the last 12 months and more than 415% since April 2024. In April, the stock could have been classified as a penny stock, trading around $4.50 per share. Gold is up almost $2,000 an ounce in the past year, catching many on Wall Street by surprise. But one analyst predicted the move. Right after Trump's election, he called for gold to pass $3,200, and it happened within two days. He said it would soar past $4,100, and it did within two months. He predicted $5,000 early in 2026, and that just happened. Now he says gold is headed to $7,000 soon with $10,000 on the near horizon. But despite gold's run, there's a way to make even more, an approach that has delivered 31, 65, even 469 times higher gains than gold itself. Learn the critical details now. Many investors may have anticipated the move because Alignment Healthcare operates in Medicare Advantage and focuses on value-based care. The company's integrated model combines in-home clinical services, telehealth capabilities, and digital health tools. Over the past two years, health insurance stocks—particularly those tied to Medicare Advantage—have posted strong gains, benefiting from scale, pricing power, and a growing senior population. The Broader Healthcare Trend Is Turning According to The Wall Street Journal, beaten-down hospital stocks are expected to rally. Cost inflation is easing, staffing conditions are improving, and reimbursement rates are beginning to stabilize. As these headwinds let up, investor sentiment toward the broader healthcare services ecosystem is likely to improve, including companies tied to Medicare utilization and senior care. That's why investors can still be bullish on ALHC stock. The company's 18-month rally marks a fundamental reset in how investors view the company's business model. Medicare Advantage insurers faced a difficult stretch in 2023 and early 2024 driven by higher medical costs and reimbursement uncertainty. However, Alignment began demonstrating tangible progress in controlling expenses—medical cost trends improved, risk adjustment capture strengthened, and management shifted toward more disciplined growth. That efficiency appears to have convinced investors that Alignment's value-based care strategy can scale profitably. Equally important, the period when much of the bad news was already priced in offered investors leveraged exposure to a potential Medicare rebound. As fears around margin compression have faded, the stock has benefited from both a fundamental re-rating and technical tailwinds, including short covering and renewed interest in mid-cap healthcare names. If hospital economics and Medicare utilization continue to normalize as expected in 2026, Alignment's integrated care model and its positioning in the mid-cap sector could make it a beneficiary of improving industry conditions. ALHC Stock Looks Overbought, But the Uptrend Is Intact For all the reasons investors might buy ALHC stock, now may not present the best entry. ALHC is technically extended, pushing to new 52‑week highs and trading well above key moving averages—signaling a strong but stretched uptrend. The daily RSI in the low‑70s and a strongly positive MACD reflect overbought momentum rather than a low‑risk entry, so chasing at current levels offers poor risk‑reward even though the trend remains bullish. 
A better approach for investors who have been on the sidelines is to stay constructive on the name but wait for a pullback into support. The first buy zone is around $21.50 to $22 — an area of recent consolidation just below the highs where an initial bounce would favor more aggressive entries. A more conservative, higher‑probability zone is $20.25–$20.75, near the rising 50‑day moving average and the prior base. If the stock can hold these levels, it would confirm trend integrity. Traders could scale in around the upper zone and add closer to the 50‑day, using a stop just below the 20‑day SMA to define risk while targeting a retest and modest extension of the highs in the $24–$25 region, as long as pullbacks remain orderly and support holds.
|
Post a Comment
Post a Comment